Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Minoxidil 5% helps with patchy alopecia areata, but more research is needed.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

PRP is effective for treating patchy alopecia areata.

PRP therapy significantly improved hair growth in a girl with chronic alopecia areata.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Hemp seed oil shows promise in treating localized alopecia areata.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

DPCP can help regrow hair in some people with severe alopecia.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Exclamation mark hairs help distinguish syphilitic alopecia from alopecia areata.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Environmental factors can trigger alopecia areata in identical twins.